{"transactions":[{"id":742954,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-10T20:10:05.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001276038-26-000006","document":"form4-06102026_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000127603826000006/form4-06102026_040601.xml","form_type":"4"}},{"id":742953,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:10:05.000Z","date":"2026-06-08","kind":"exercise","planned":false,"acquired":true,"shares":8700,"price":16.49,"value":143463.0,"ownership":{"direct":true},"balance_after":112483,"source":{"system":"sec-edgar","filing":"0001276038-26-000006","document":"form4-06102026_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000127603826000006/form4-06102026_040601.xml","form_type":"4"}},{"id":769830,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:05:09.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":20,"price":34.05,"value":681.0,"ownership":{"direct":true},"balance_after":83952,"source":{"system":"sec-edgar","filing":"0001296771-26-000004","document":"form4-05202026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000129677126000004/form4-05202026_040501.xml","form_type":"4"}},{"id":774869,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:27.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":26758,"source":{"system":"sec-edgar","filing":"0001450485-26-000009","document":"form4-05182026_040516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000009/form4-05182026_040516.xml","form_type":"4"}},{"id":774715,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:24.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":28323,"source":{"system":"sec-edgar","filing":"0001606244-26-000002","document":"form4-05182026_040514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000160624426000002/form4-05182026_040514.xml","form_type":"4"}},{"id":774741,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-05-18T20:15:22.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001296771-26-000002","document":"form4-05182026_040512.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000129677126000002/form4-05182026_040512.xml","form_type":"4"}},{"id":774740,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:22.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":4127,"price":34.54,"value":142546.58,"ownership":{"direct":true},"balance_after":83972,"source":{"system":"sec-edgar","filing":"0001296771-26-000002","document":"form4-05182026_040512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000129677126000002/form4-05182026_040512.xml","form_type":"4"}},{"id":774739,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:22.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":8700,"price":16.49,"value":143463.0,"ownership":{"direct":true},"balance_after":88099,"source":{"system":"sec-edgar","filing":"0001296771-26-000002","document":"form4-05182026_040512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000129677126000002/form4-05182026_040512.xml","form_type":"4"}},{"id":774738,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:22.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":79399,"source":{"system":"sec-edgar","filing":"0001296771-26-000002","document":"form4-05182026_040512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000129677126000002/form4-05182026_040512.xml","form_type":"4"}},{"id":774714,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":46384,"kind":"person","name":"Glancy Donovan Michael","position":1,"cik":"0002134015","reported_name":"Glancy Donovan Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:21.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":17482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 8,741 of the RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders; 8,741 of the RSUs vest on May 14, 2027, in each case subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":17482,"source":{"system":"sec-edgar","filing":"0002134015-26-000005","document":"form4-05182026_040517.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000213401526000005/form4-05182026_040517.xml","form_type":"4"}},{"id":774713,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:21.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":71000,"source":{"system":"sec-edgar","filing":"0001254705-26-000004","document":"form4-05182026_040510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000004/form4-05182026_040510.xml","form_type":"4"}},{"id":774712,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":46383,"kind":"person","name":"Balice-Gordon Rita J.","position":1,"cik":"0001825625","reported_name":"Balice-Gordon Rita J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:18.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":61370,"source":{"system":"sec-edgar","filing":"0001825625-26-000002","document":"form4-05182026_040509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000182562526000002/form4-05182026_040509.xml","form_type":"4"}},{"id":774719,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:15:17.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":8741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":103783,"source":{"system":"sec-edgar","filing":"0001276038-26-000002","document":"form4-05182026_040507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000127603826000002/form4-05182026_040507.xml","form_type":"4"}},{"id":776963,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:05:10.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":4500,"price":35.9691,"value":161860.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.55 to $36.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18017,"source":{"system":"sec-edgar","filing":"0001450485-26-000007","document":"form4-05152026_040505.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000145048526000007/form4-05152026_040505.xml","form_type":"4"}},{"id":780639,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":780638,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":8700,"price":37.1829,"value":323491.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.18 to $37.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":62259,"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":780637,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-13T20:05:05.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":8700,"price":16.49,"value":143463.0,"ownership":{"direct":true},"balance_after":70959,"source":{"system":"sec-edgar","filing":"0001254705-26-000002","document":"form4-05132026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000125470526000002/form4-05132026_040501.xml","form_type":"4"}},{"id":817231,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-04-03T20:46:19.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":8840,"price":35.72,"value":315764.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."}],"balance_after":68231,"source":{"system":"sec-edgar","filing":"0002061438-26-000009","document":"form4-04032026_080415.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000009/form4-04032026_080415.xml","form_type":"4"}},{"id":832615,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-20T21:14:50.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":13976,"price":34.9241,"value":488099.2216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.74 to $35.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":77071,"source":{"system":"sec-edgar","filing":"0002061438-26-000006","document":"form4-03202026_090345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000006/form4-03202026_090345.xml","form_type":"4"}},{"id":849149,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-03-11T20:10:23.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":6224,"price":36.65,"value":228109.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025."}],"balance_after":91047,"source":{"system":"sec-edgar","filing":"0002061438-26-000004","document":"form4-03112026_080318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000004/form4-03112026_080318.xml","form_type":"4"}},{"id":858096,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:29:50.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":3559,"price":40.9889,"value":145879.4951,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.84 to $41.35, inclusive."}],"balance_after":71770,"source":{"system":"sec-edgar","filing":"0001746251-26-000004","document":"form4-03052026_090346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000004/form4-03052026_090346.xml","form_type":"4"}},{"id":858095,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:29:50.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":46417,"price":40.3636,"value":1873557.2212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.835 to $40.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":75329,"source":{"system":"sec-edgar","filing":"0001746251-26-000004","document":"form4-03052026_090346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000004/form4-03052026_090346.xml","form_type":"4"}},{"id":907904,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:23.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2781,"price":46.75,"value":130011.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":97271,"source":{"system":"sec-edgar","filing":"0002061438-26-000002","document":"form4-02122026_040219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000002/form4-02122026_040219.xml","form_type":"4"}},{"id":907903,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:23.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":9005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 9,005 performance share units (\"PSUs\") granted in the Issuer's 2025 fiscal year."}],"balance_after":100052,"source":{"system":"sec-edgar","filing":"0002061438-26-000002","document":"form4-02122026_040219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000002/form4-02122026_040219.xml","form_type":"4"}},{"id":907902,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:23.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":22194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 404 shares acquired on January 16, 2026 under the Issuer's employee stock purchase plan."}],"balance_after":91047,"source":{"system":"sec-edgar","filing":"0002061438-26-000002","document":"form4-02122026_040219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000206143826000002/form4-02122026_040219.xml","form_type":"4"}},{"id":907383,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11296,"price":46.75,"value":528088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":197864,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":907382,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":32531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,531 performance share units (\"PSUs\") granted in the Issuer's 2025 fiscal year."}],"balance_after":209160,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":907381,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":79264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 376 shares acquired on July 18, 2025 under the Issuer's employee stock purchase plan."}],"balance_after":176629,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":907380,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:19.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11538,"price":46.75,"value":539401.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":90651,"source":{"system":"sec-edgar","filing":"0001748462-26-000002","document":"form4-02122026_040205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174846226000002/form4-02122026_040205.xml","form_type":"4"}},{"id":907379,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:19.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":5897,"price":46.75,"value":275684.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":102189,"source":{"system":"sec-edgar","filing":"0001748462-26-000002","document":"form4-02122026_040205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174846226000002/form4-02122026_040205.xml","form_type":"4"}},{"id":907378,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:19.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":22774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 22,774 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":108086,"source":{"system":"sec-edgar","filing":"0001748462-26-000002","document":"form4-02122026_040205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174846226000002/form4-02122026_040205.xml","form_type":"4"}},{"id":907377,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:19.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":14268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 376 and 404 shares acquired on July 18, 2025 and January 16, 2026, respectively, under the Issuer's employee stock purchase plan."}],"balance_after":85312,"source":{"system":"sec-edgar","filing":"0001748462-26-000002","document":"form4-02122026_040205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174846226000002/form4-02122026_040205.xml","form_type":"4"}},{"id":907376,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21615,"price":46.75,"value":1010501.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":121746,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907375,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":9977,"price":46.75,"value":466424.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":143361,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907374,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":30702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 30,702 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":153338,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907373,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:09.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":19023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":122636,"source":{"system":"sec-edgar","filing":"0001746251-26-000002","document":"form4-02122026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625126000002/form4-02122026_040201.xml","form_type":"4"}},{"id":907739,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":26679,"price":46.75,"value":1247243.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":147282,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907738,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11861,"price":46.75,"value":554501.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":173961,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907737,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":32734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,734 performance share units (\"PSUs\") granted in the Issuer's three prior fiscal years."}],"balance_after":185822,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":907736,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T16:30:11.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":26421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":153088,"source":{"system":"sec-edgar","filing":"0001862082-26-000002","document":"form4-02122026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208226000002/form4-02122026_040203.xml","form_type":"4"}},{"id":974317,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":17600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":17600},"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974316,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":6475,"price":48.6617,"value":315084.5075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.215 to $49.08, inclusive."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974315,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":11125,"price":47.8895,"value":532770.6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.212 to $48.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":110088,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":974314,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-10T21:32:40.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":17600,"price":15.9,"value":279840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025."}],"balance_after":121213,"source":{"system":"sec-edgar","filing":"0001746251-25-000004","document":"form4-12102025_091236.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000174625125000004/form4-12102025_091236.xml","form_type":"4"}},{"id":975862,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":46383,"kind":"person","name":"Balice-Gordon Rita J.","position":1,"cik":"0001825625","reported_name":"Balice-Gordon Rita J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T21:22:58.000Z","date":"2025-12-05","kind":"sale","planned":false,"acquired":false,"shares":3650,"price":47.0338,"value":171673.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.0301 to $47.0901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52629,"source":{"system":"sec-edgar","filing":"0001825625-25-000004","document":"form4-12092025_091255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000182562525000004/form4-12092025_091255.xml","form_type":"4"}},{"id":998767,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-14T21:13:00.000Z","date":"2025-11-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":8983,"price":47.35,"value":425345.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."}],"balance_after":96989,"source":{"system":"sec-edgar","filing":"0001699488-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948825000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998772,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":19853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.33,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":19853},"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998771,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.49,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998770,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"sale","planned":false,"acquired":false,"shares":34853,"price":47.2136,"value":1645535.6008,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64634,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998769,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":19853,"price":9.33,"value":185228.49,"ownership":{"direct":true},"balance_after":99487,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":998768,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T21:10:00.000Z","date":"2025-11-12","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":16.49,"value":247350.0,"ownership":{"direct":true},"balance_after":79634,"source":{"system":"sec-edgar","filing":"0001560152-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000156015225000004/form4-11142025_091156.xml","form_type":"4"}},{"id":1004981,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T16:23:09.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":4858,"price":41.2756,"value":200516.8648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.00 to $41.75, inclusive."}],"balance_after":126667,"source":{"system":"sec-edgar","filing":"0001862082-25-000004","document":"form4-11072025_091106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208225000004/form4-11072025_091106.xml","form_type":"4"}},{"id":1004980,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T16:23:09.000Z","date":"2025-11-06","kind":"sale","planned":true,"acquired":false,"shares":25142,"price":40.3801,"value":1015236.4742,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":131525,"source":{"system":"sec-edgar","filing":"0001862082-25-000004","document":"form4-11072025_091106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000186208225000004/form4-11072025_091106.xml","form_type":"4"}},{"id":1049386,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-03T20:56:45.000Z","date":"2025-08-29","kind":"sale","planned":false,"acquired":false,"shares":17478,"price":38.4241,"value":671576.4198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.37 to $38.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70264,"source":{"system":"sec-edgar","filing":"0001062993-25-015277","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325015277/form4.xml","form_type":"4"}},{"id":1060101,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":false,"shares":16389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":16389},"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1060100,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"sale","planned":true,"acquired":false,"shares":16389,"price":38.2068,"value":626171.2452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1060099,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T20:57:07.000Z","date":"2025-08-18","kind":"exercise","planned":true,"acquired":true,"shares":16389,"price":21.34,"value":349741.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."}],"balance_after":120002,"source":{"system":"sec-edgar","filing":"0001062993-25-014766","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014766/form4.xml","form_type":"4"}},{"id":1061561,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-19T21:10:43.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.45,"expiration_date":"2025-09-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001062993-25-014694","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000106299325014694/form4.xml","form_type":"4"}},{"id":1061560,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T21:10:43.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":5405,"price":37.1912,"value":201018.436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.17 to $37.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":95042,"source":{"system":"sec-edgar","filing":"0001062993-25-014694","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000106299325014694/form4.xml","form_type":"4"}},{"id":1061559,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-19T21:10:43.000Z","date":"2025-08-15","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":13.45,"value":201750.0,"ownership":{"direct":true},"balance_after":100447,"source":{"system":"sec-edgar","filing":"0001062993-25-014694","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000106299325014694/form4.xml","form_type":"4"}},{"id":1065186,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":false,"shares":4861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":16389,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":4861},"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1065185,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"sale","planned":true,"acquired":false,"shares":4861,"price":38.0335,"value":184880.8435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1065184,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:08:54.000Z","date":"2025-08-13","kind":"exercise","planned":true,"acquired":true,"shares":4861,"price":21.34,"value":103733.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."}],"balance_after":108474,"source":{"system":"sec-edgar","filing":"0001062993-25-014526","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325014526/form4.xml","form_type":"4"}},{"id":1065465,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":74187,"kind":"organization","name":"Rubric Capital Management LP","position":1,"cik":"0001687509","reported_name":"Rubric Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74188,"kind":"person","name":"Rosen David Efraim","position":2,"cik":"0001898677","reported_name":"Rosen David Efraim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-08-15T16:12:20.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":37.85,"value":946250.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.71 to $38.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is filed by Rubric Capital Management LP (\"Rubric Capital\") and Mr. David Rosen, with respect to the securities held by certain funds and/or accounts (collectively, the \"Rubric Vehicles\"). Rubric Capital serves as the investment adviser to the Rubric Vehicles. Mr. David Rosen serves as the Managing Member of Rubric Capital Management GP, LLC, the general partner of Rubric Capital."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any."}],"balance_after":3132743,"source":{"system":"sec-edgar","filing":"0000902664-25-003729","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898677/000090266425003729/ownership.xml","form_type":"4"}},{"id":1068765,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T21:18:53.000Z","date":"2025-08-08","kind":"sale","planned":false,"acquired":false,"shares":11659,"price":34.3632,"value":400640.5488,"ownership":{"direct":false,"nature":"By: John Freund Family Partnership IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.27 to $34.535, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by the John Freund Family Partnership IV, L.P. (\"Freund LP\"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein."}],"balance_after":23129,"source":{"system":"sec-edgar","filing":"0001062993-25-014202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000106299325014202/form4.xml","form_type":"4"}},{"id":1114781,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-11T21:04:15.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.45,"expiration_date":"2025-09-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001062993-25-011425","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000106299325011425/form4.xml","form_type":"4"}},{"id":1114780,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:04:15.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":6601,"price":30.624,"value":202149.024,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.62 to $30.628, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":70658,"source":{"system":"sec-edgar","filing":"0001062993-25-011425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000106299325011425/form4.xml","form_type":"4"}},{"id":1114779,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T21:04:15.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":13.45,"value":201750.0,"ownership":{"direct":true},"balance_after":77259,"source":{"system":"sec-edgar","filing":"0001062993-25-011425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000106299325011425/form4.xml","form_type":"4"}},{"id":1142359,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":73117,"kind":"person","name":"Fallon John A.","position":1,"cik":"0001560152","reported_name":"Fallon John A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:43:54.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":64634,"source":{"system":"sec-edgar","filing":"0001062993-25-009810","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009810/form4.xml","form_type":"4"}},{"id":1142546,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44699,"kind":"person","name":"Lurker Nancy","position":1,"cik":"0001450485","reported_name":"Lurker Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:43:15.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":22517,"source":{"system":"sec-edgar","filing":"0001062993-25-009809","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1450485/000106299325009809/form4.xml","form_type":"4"}},{"id":1142360,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":44152,"kind":"person","name":"BOHLIN GAREN G","position":1,"cik":"0001254705","reported_name":"BOHLIN GAREN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:42:47.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":62259,"source":{"system":"sec-edgar","filing":"0001062993-25-009808","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009808/form4.xml","form_type":"4"}},{"id":1142358,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":46383,"kind":"person","name":"Balice-Gordon Rita J.","position":1,"cik":"0001825625","reported_name":"Balice-Gordon Rita J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:42:31.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":56279,"source":{"system":"sec-edgar","filing":"0001062993-25-009807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009807/form4.xml","form_type":"4"}},{"id":1142393,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":40449,"kind":"person","name":"Freund John Gordon","position":1,"cik":"0001296771","reported_name":"Freund John Gordon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:42:13.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":62259,"source":{"system":"sec-edgar","filing":"0001062993-25-009806","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1296771/000106299325009806/form4.xml","form_type":"4"}},{"id":1142367,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":13210,"kind":"person","name":"SANTINI GINO","position":1,"cik":"0001276038","reported_name":"SANTINI GINO","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:39:09.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":9791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":85447,"source":{"system":"sec-edgar","filing":"0001062993-25-009805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1276038/000106299325009805/form4.xml","form_type":"4"}},{"id":1142357,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":37686,"kind":"person","name":"Paya Carlos V","position":1,"cik":"0001606244","reported_name":"Paya Carlos V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T21:37:56.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. 9,791 of the RSUs vest on the earlier of May 15, 2026, or the date of the Issuer's 2026 Annual Meeting of Shareholders; 9,791 of the RSUs vest on May 15, 2026, in each case subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock."}],"balance_after":19582,"source":{"system":"sec-edgar","filing":"0001062993-25-009804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325009804/form4.xml","form_type":"4"}},{"id":1193302,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T21:05:13.000Z","date":"2025-03-21","kind":"sale","planned":true,"acquired":false,"shares":18881,"price":30.0293,"value":566983.2133,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.48, inclusive."}],"balance_after":103613,"source":{"system":"sec-edgar","filing":"0001062993-25-006148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325006148/form4.xml","form_type":"4"}},{"id":1193301,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T21:05:13.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":1927,"price":30.0005,"value":57810.9635,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":122494,"source":{"system":"sec-edgar","filing":"0001062993-25-006148","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325006148/form4.xml","form_type":"4"}},{"id":1193626,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T17:06:10.000Z","date":"2025-03-21","kind":"sale","planned":true,"acquired":false,"shares":6396,"price":30.0295,"value":192068.682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive."}],"balance_after":156667,"source":{"system":"sec-edgar","filing":"0001062993-25-006149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325006149/form4.xml","form_type":"4"}},{"id":1193625,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-24T17:06:10.000Z","date":"2025-03-20","kind":"sale","planned":true,"acquired":false,"shares":1206,"price":30.0011,"value":36181.3266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":163063,"source":{"system":"sec-edgar","filing":"0001062993-25-006149","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325006149/form4.xml","form_type":"4"}},{"id":1197423,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":53930,"kind":"person","name":"Dieter David","position":1,"cik":"0002061438","reported_name":"Dieter David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2025-03-19T20:36:33.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":68449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Thirty-three percent (33%) of the RSUs shall vest on March 17, 2026, with the balance vesting in two annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":68449,"source":{"system":"sec-edgar","filing":"0001062993-25-005904","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2061438/000106299325005904/form4.xml","form_type":"4"}},{"id":1199276,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T23:18:19.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":15387,"price":30.004,"value":461671.548,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on March 13, 2025 on behalf of the Reporting Person inadvertently reported the incorrect transaction date. As reported in this amendment, the correct transaction date is March 11, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":126676,"source":{"system":"sec-edgar","filing":"0001062993-25-005834","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005834/form4a.xml","form_type":"4/A","original_submission_date":"2025-03-13"}},{"id":1199275,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:34:13.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":2255,"price":30.0049,"value":67661.0495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":124421,"source":{"system":"sec-edgar","filing":"0001062993-25-005752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005752/form4.xml","form_type":"4"}},{"id":1200298,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T17:35:14.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":977,"price":30.0034,"value":29313.3218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":164269,"source":{"system":"sec-edgar","filing":"0001062993-25-005753","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005753/form4.xml","form_type":"4"}},{"id":1207536,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T20:50:14.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":15387,"price":30.004,"value":461671.548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":126676,"source":{"system":"sec-edgar","filing":"0001062993-25-005396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005396/form4.xml","form_type":"4"}},{"id":1207895,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T16:49:26.000Z","date":"2025-03-11","kind":"sale","planned":true,"acquired":false,"shares":10445,"price":30.006,"value":313412.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":165246,"source":{"system":"sec-edgar","filing":"0001062993-25-005395","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005395/form4.xml","form_type":"4"}},{"id":1214869,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:01:39.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":2348,"price":30.0025,"value":70445.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive."}],"balance_after":142063,"source":{"system":"sec-edgar","filing":"0001062993-25-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005020/form4.xml","form_type":"4"}},{"id":1214868,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:01:39.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":3295,"price":30.0011,"value":98853.6245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":144411,"source":{"system":"sec-edgar","filing":"0001062993-25-005020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325005020/form4.xml","form_type":"4"}},{"id":1215247,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T16:02:15.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":1504,"price":30.0007,"value":45121.0528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2)."}],"balance_after":175691,"source":{"system":"sec-edgar","filing":"0001062993-25-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005021/form4.xml","form_type":"4"}},{"id":1215246,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66730,"kind":"person","name":"Tupper Colleen","position":1,"cik":"0001862082","reported_name":"Tupper Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-10T16:02:15.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":1949,"price":30,"value":58470.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024."}],"balance_after":177195,"source":{"system":"sec-edgar","filing":"0001062993-25-005021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862082/000106299325005021/form4.xml","form_type":"4"}},{"id":1219628,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":24.03,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219627,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":26067,"price":28.5014,"value":742945.9938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.50 to $28.58, inclusive."}],"balance_after":108137,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219626,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-05","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":28.0264,"value":560528.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.18, inclusive."}],"balance_after":134204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219625,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":28.079,"value":1123160.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4."}],"balance_after":154204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1219624,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":82297,"kind":"person","name":"Kuhlmann Shirley R.","position":1,"cik":"0001734919","reported_name":"Kuhlmann Shirley R.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and General Counsel"}}],"security":"Common Stock","published_at":"2025-03-06T18:48:35.000Z","date":"2025-03-04","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":24.03,"value":961200.0,"ownership":{"direct":true},"balance_after":194204,"source":{"system":"sec-edgar","filing":"0001062993-25-004776","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734919/000106299325004776/form4.xml","form_type":"4"}},{"id":1271538,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":37240,"kind":"person","name":"Heffernan Michael Thomas","position":1,"cik":"0001448914","reported_name":"Heffernan Michael Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-12T21:10:53.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of fully-vested restricted stock units (\"RSUs\") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":50328,"source":{"system":"sec-edgar","filing":"0001062993-25-002181","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448914/000106299325002181/form4.xml","form_type":"4"}},{"id":1271343,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:38.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4399,"price":30.52,"value":134257.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":87742,"source":{"system":"sec-edgar","filing":"0001062993-25-002180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002180/form4.xml","form_type":"4"}},{"id":1271342,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:38.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1498,"price":30.52,"value":45718.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":92141,"source":{"system":"sec-edgar","filing":"0001062993-25-002180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002180/form4.xml","form_type":"4"}},{"id":1271341,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:38.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 5,313 performance share units (\"PSUs\") granted in the Issuer's prior fiscal year."}],"balance_after":93639,"source":{"system":"sec-edgar","filing":"0001062993-25-002180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002180/form4.xml","form_type":"4"}},{"id":1271340,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66690,"kind":"person","name":"Smith Thomas B","position":1,"cik":"0001748462","reported_name":"Smith Thomas B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:38.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":33762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 373 and 375 shares acquired on July 19, 2024 and January 17, 2025, respectively, under the Issuer's employee stock purchase plan."}],"balance_after":88326,"source":{"system":"sec-edgar","filing":"0001062993-25-002180","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002180/form4.xml","form_type":"4"}},{"id":1271335,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":62525,"kind":"person","name":"Dreyer Scott","position":1,"cik":"0001746251","reported_name":"Dreyer Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:10:22.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":21670,"price":30.52,"value":661368.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs."}],"balance_after":147706,"source":{"system":"sec-edgar","filing":"0001062993-25-002179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299325002179/form4.xml","form_type":"4"}}],"next_cursor":"2025-02-12T21:10:22.000000Z,1271335"}